← Leaderboards
Krista L. Lanctot
University Of California Los Angeles
$2,122,884
Attributed
$9,575,206
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2008–18$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$9,575,206 · 5
By mechanism
R01$9,557,067 · 2
P41$18,139 · 3
Top collaborators
- Jacobo E. Mintzer12 shared
- Paul B Rosenberg12 shared
- Nathan Herrmann10 shared
- Roberta W Scherer9 shared
- David M Shade1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Lori L Altshuler$13,296,561
- Jerome M Siegel$29,376,264
- Susan Y Bookheimer$37,624,801
- Gary William Small$17,082,455
- Helen Lavretsky$17,053,369
Others in their field
Top investigators on “S Disease”
- Lawrence Corey · Fred Hutchinson Cancer Center$643,566,627
- Jeffrey P Krischer · University Of South Florida$588,279,843
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$477,614,997
- David Heimbrook · Leidos Biomedical Research, Inc.$470,438,912
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$389,132,404
Research focus
S DiseaseAlzheimer&AposPharmaceutical PreparationsCognitionActivities Of Daily LivingInterestNeuropsychiatryResearch PersonnelCognitive FunctionResourcesCognitiveElementsAdverse EventClinically SignificantAffectiveEmotionalEquipment And Supply InventoriesEconomic CostAffectDementiaCaregiversBehavior MeasurementElectrocardiogramDirect Costs
Grant awards (15)
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$1,297,999
R01 · FY2018 · AG
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$367,383
R01 · FY2018 · AG
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$172,427
R01 · FY2018 · AG
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$100,000
R01 · FY2018 · AG
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$1,455,745
R01 · FY2017 · AG
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$144,804
R01 · FY2017 · AG
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$1,451,083
R01 · FY2016 · AG
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$100,000
R01 · FY2016 · AG
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$1,426,649
R01 · FY2015 · AG
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$1,590,989
R01 · FY2014 · AG
Apathy in Alzheimer's Disease Methylphenidate Trial$709,569
R01 · FY2010 · AG
A POSITRON EMISSSION TOMOGRAPHY STUDY OF 5-HT1A RECEPTORS IN ALZHEIMER'S DISEASE$12,157
P41 · FY2010 · RR · contact PI
Apathy in Alzheimer's Disease Methylphenidate Trial$740,419
R01 · FY2009 · AG
A POSITRON EMISSSION TOMOGRAPHY STUDY OF 5-HT1A RECEPTORS IN ALZHEIMER'S DISEASE$3,406
P41 · FY2009 · RR · contact PI
A POSITRON EMISSSION TOMOGRAPHY STUDY OF 5-HT1A RECEPTORS IN ALZHEIMER'S DISEASE$2,576
P41 · FY2008 · RR · contact PI